CVX slips 6% post-earnings as options defensiveness builds

Options traders signalled the defensiveness before the fall. The put/call ratio is running at 0.85 — about 1.9 standard deviations above its 20-day average of 0.79 — and is closing in on its 52-week high of 0.93. That degree of protective positioning is unusual for a mega-cap integrated name, and in retrospect reflected genuine unease ahead of the print. The borrow market, by contrast, remains completely untroubled: availability is at its maximum recorded level, with over 1.7 billion shares available to borrow against roughly 18 million shorted. Cost to borrow is 0.32%, barely changed on the week. Short interest itself is negligible at 0.91% of free float — a level that has remained essentially flat through the selloff. There is no short-covering tailwind, but equally no crowded bear trade.

The Street's reaction to results has been constructive at the margin, which makes the price decline harder to dismiss as purely analyst-driven. Mizuho lifted its target to $230 just this morning, maintaining Outperform. Barclays raised to $213 yesterday from $192 while holding Equal-Weight — notably, Barclays had already lifted from $180 to $192 on May 4, so this is a second consecutive upward revision. Morgan Stanley edged its target up to $214 earlier in the week. The direction of travel is upward across most desks. Only Bernstein moved in the opposite direction, trimming to $204 from $216 on May 11. The consensus mean of $215.87 now implies 17% upside from current levels — wider than it has been in recent months. The bull case rests on FCF growth from two key upstream assets and a 4% dividend yield that ranks in the 96th percentile for income quality. The bear case centres on crude price sensitivity and execution risk in international operations.

One ownership detail worth flagging: John B. Hess, who joined the Chevron board following the Hess Corporation acquisition, sold approximately $73 million worth of CVX shares on May 20 across multiple tranches at prices between $192 and $197. The sales came near the recent high and just ahead of the earnings-driven selloff. The trades carry a relatively modest significance score, but the timing and scale — combined with continued selling from the same insider at lower prices in early May — make them notable context.

The next earnings date is July 31. Between now and then, the widening gap between the current price and consensus targets, combined with still-elevated options defensiveness, frames the question plainly: whether analysts begin revising targets down toward the stock, or whether the stock recovers toward the targets.